Repligen Q2 GAAP EPS drops 65.38% to $0.09; revenue rises 12% to $204 millionPUBT·49 minutes agoRGEN-0.68%BLFS-0.63%
Cross-Sector Divergence: How Global Shifts Fracture US and International Equities in Mid-2026Global Report·2 hours agoLSRCY-1.37%DHI+0.61%
Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders?PR Newswire·Jul 23 at 11:10 AMFNWD-0.83%UTZ-0.14%
Is Repligen (RGEN) Still Undervalued Following Its $1.5b BioLife Deal?Simplywall·Jul 23 at 08:19 AMRGEN-0.68%BLFS-0.63%
Biotech Stocks At 52-Week Highs - ADVB Surges +73%, BLFS Rises After Acquisition, FBRX, SLN, LBRXrttnews·Jul 23 at 03:38 AMSLN+9.53%FBRX+39.65%
BioLife Solutions to Be Acquired by Repligen for $11.25 Cash Plus 0.1442 Share Per ShareTradingView·Jul 22 at 04:23 PMBLFS-0.63%RGEN-0.68%
BioLife Solutions slides 1% in after-hours trading after 7% intraday surgeUS Stock Market Update·Jul 22 at 04:21 PMBLFS-0.63%
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media | RGEN Stock NewsStockTitan·Jul 21 at 09:00 PMBLFS-0.63%RGEN-0.68%
BioLife Solutions climbs 8% on $1.5B Repligen acquisition dealUS Stock Market Update·Jul 22 at 01:51 PMBLFS-0.63%
